By Business/Source
Currency:JPY
2025/FY
Stock NameRevenueRatio
Research and development, purchasing, manufacturing, and sales of prescription pharmaceuticals, as438.27B100.00%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
United Kingdom245.51B56.02%
Japan130B29.66%
United States23.44B5.35%
Europe20.16B4.60%
Others19.15B4.37%
